Performance Feedback in Health Care
The Southeast Permanente Medical Group (TSPMG) at Kaiser Permanente Georgia provides performance feedback to its providers. The performance feedback designs can vary and change over time in terms of targets, summary statistics, included measures, and frequency of delivery. The TSPMG health services research group seek to compare different performance feedback designs to identify which are most effective at contributing to performance improvement.
The research team will randomly assign providers into different performance feedback conditions, as specified in the protocol. Providers will receive performance feedback through the standard mechanism in which it is conveyed by their supervisor.
The objective is to investigate how to design performance feedback for providers to best motivate and support them in improving performance along with existing strategic priorities for care delivery.
The reserach team will test alternative designs of performance feedback that vary on the following dimension:
1) targets for comparison of one's own performance
Przegląd badań
Status
Warunki
Szczegółowy opis
The Southeast Permanente Medical Group (TSPMG) provides performance feedback to its providers. The performance feedback designs can vary and change over time in terms of targets, summary statistics, included measures, and frequency of delivery. The TSPMG health services research team will seek to compare different performance feedback designs to identify which are most effective at contributing to performance improvement. .
The research team will randomly assign providers into different performance feedback conditions, as specified in the protocol. Providers will receive performance feedback through the standard mechanism in which it is conveyed by their supervisor.
The objective is to investigate how to design performance feedback for providers to best motivate and support them in improving performance along with existing strategic priorities for care delivery.
The research team will test alternative designs of performance feedback that vary on the following dimension:
1) targets for comparison of one's own performance
The research team will provide feedback on performance by measures that the organization already tracks internally and uses for performance improvement. These include a provider's utilization of opportunities to provide flu vaccinations.
The study will randomly assign different designs of feedback to providers. In order to understand which designs of feedback have the best effects on performance, the research team will test the following hypotheses:
Displaying the next-highest quartile will motivate improvement more than display of all quartiles.
Theory: The next-highest quartile will serve as an injunctive norm, or suggested target, to repeatedly lift an individual's performance to the suggested level.
The positive effect of displaying the next-highest quartile, relative to displaying all quartiles, will be most pronounced for initially low performers.
Theory: The next highest quartile averts upward social comparison to a much higher level of peer performance, which can be discouraging and so negatively affect performance
The positive effect of displaying the next-highest quartile, relative to displaying all quartiles, will diminish over time.
Theory: Individuals may become worn out as they see a target ratchet higher when their performance improves.
- Displaying team relative performance along with individual relative performance will be more effective than displaying either type of information alone.
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
Georgia
-
Atlanta, Georgia, Stany Zjednoczone, 30305
- Kaiser Permanente Georgia Regional Offices
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
- Dziecko
- Dorosły
- Starszy dorosły
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
A healthcare provider practicing at The Southeast Permanente Medical Group in a specialty for which the performance measure being studied is relevant.
Health care providers include:
Physicians, Nurse Practitioner, Certified Nurse Midwife, Psych Nurse Specialist, Optometrist, Podiatrist, and Physician Assistant
Exclusion Criteria:
Non-Physicians: Registered Nurses excluding nurse practitioners
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Badania usług zdrowotnych
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Pojedynczy
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
|---|---|
|
Aktywny komparator: Organizational Target
Providers are shown the flu success performance rate of their team (a "pod," or group of providers who practice together), in comparison to their own, and with the organizational target.
These updates and targets are sent bi-weekly.
|
A given provider will be involved in the study for a maximum of 6 months. This will involve, at the most frequent, the delivery of weekly performance feedback. The performance feedback will be delivered using standard approaches already in place in the organization and there will not be a period of seeking out participants for enrollment. Providers will receive performance feedback bi-weekly for the duration of the study period. |
|
Eksperymentalny: Achievable Target
Providers are shown the flu success performance rate of their team (a "pod," or group of providers who practice together), in comparison to their own.
They will receive a static and achievable target based on their previous year's flu vaccination success rate.
|
A given provider will be involved in the study for a maximum of 6 months. This will involve, at the most frequent, the delivery of weekly performance feedback. The performance feedback will be delivered using standard approaches already in place in the organization and there will not be a period of seeking out participants for enrollment. Providers will receive performance feedback bi-weekly for the duration of the study period. |
|
Eksperymentalny: Variable
Providers are shown the flu success performance rate of their team (a "pod," or group of providers who practice together), in comparison to their own.
They will receive a variable target that will fluctuate bi-weekly, based on their previous bi-weekly flu vaccination success rate.
|
A given provider will be involved in the study for a maximum of 6 months. This will involve, at the most frequent, the delivery of weekly performance feedback. The performance feedback will be delivered using standard approaches already in place in the organization and there will not be a period of seeking out participants for enrollment. Providers will receive performance feedback bi-weekly for the duration of the study period. |
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Flu Vaccination Administered During Encounter
Ramy czasowe: 10 Weeks
|
Whether or not the providers succeeded in administering flu vaccination during flu vaccination opportunity
|
10 Weeks
|
Współpracownicy i badacze
Sponsor
Współpracownicy
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Inne numery identyfikacyjne badania
- 1535959-1
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Grypa
-
Tanabe Pharma CorporationZakończony
-
Mexican Emerging Infectious Diseases Clinical Research...National Institute of Allergy and Infectious Diseases (NIAID); Coordinación...ZakończonyOstre infekcje dróg oddechowych | Influenza Nos lub choroba grypopodobnaMeksyk
-
Jiangsu Province Centers for Disease Control and...Chengdu Olymvax Biopharmaceuticals Inc.Zakończony
-
Jiangsu Province Centers for Disease Control and...Royal (Wuxi) Biological Co., LTDZakończonyGrupa A, C Polisacharydowe zapalenie opon mózgowych | Haemophilus influenza typu bChiny
-
University Hospital, LilleCSL Behring; Laboratoire français de Fractionnement et de Biotechnologies; Oct... i inni współpracownicyZakończonyInfekcje pneumokokowe | Zapalenie płuc, bakteryjne | Zapalenie opon mózgowych, bakteryjne | Zapalenie ucha środkowego | Przewlekła infekcja zatok | Infekcja paciorkowcowa | Niedobór przeciwciał | Niedobór dopełniacza | Zakażenia Neisseria | Haemophilus InfluenzaFrancja
-
QIAGEN Gaithersburg, IncZakończonyZakażenia syncytialnym wirusem oddechowym | Grypa A | Rinowirus | Grypa B | Panel zaawansowany QIAGEN ResPlex II | Zakażenie wywołane ludzkim wirusem paragrypy 1 | Paragrypa typu 2 | Paragrypa typu 3 | Paragrypa typu 4 | Ludzki metapneumowirus A/B | Wirus Coxsackie/echowirus | Adenowirusy typu B/C/E | Podtypy koronawirusa... i inne warunkiStany Zjednoczone